All funds

Parnassus Investments

Dec 2024 → Dec 2025 · Publishes quarterly · 8 funds

Our archive holds 14 letters from Parnassus Investments, behind 18 investment theses. Every quote below is copied verbatim from the letter it came from.

Parnassus Investments’s own letters page
14
Letters
0
Companies
0
Moves
18
Theses

Theses · 18

  • December 2025

    Ingersoll Rand Inc. is a global industrial equipment maker poised to benefit from an anticipated industrial recovery and construction megaprojects.

    Read the full thesis
  • December 2025

    CMS Energy Corp. is a well-managed Michigan utility with constructive regulation and a capital plan expected to modestly accelerate earnings growth.

    Read the full thesis
  • The Home Depot, Inc. has durable competitive advantages and secular demand drivers, with strategic investments expanding its addressable market.

    Read the full thesis
  • December 2025

    Abbott Laboratories offers durable growth from leadership in diabetes, heart health, and electrophysiology, supported by innovation and a diversified global model.

    Read the full thesis
  • Chipotle Mexican Grill Inc. is a fast-casual leader with strong brand and a unique value proposition, with new initiatives and easing inflation expected to reaccelerate growth.

    Read the full thesis
  • Waste Management, Inc. benefits from a wide-moat industry structure, pricing power, and growth from RNG, recycling, and Stericycle synergies.

    Read the full thesis
  • March 2025

    Synopsys is poised to strengthen its competitive edge in the electronic design automation market through its acquisition of Ansys and robust intellectual property, amidst the growing complexity of semiconductor design and the rise of AI accelerators.

    Read the full thesis
  • March 2025

    ICON is a leading CRO poised for growth as R&D spending rebounds and it gains market share following a recent stock sell-off.

    Read the full thesis
  • JP Morgan is a formidable player in the financial services industry due to its expertise, high client switching costs, unmatched scale, and resilience across its various banking units.

    Read the full thesis
  • December 2024

    AstraZeneca is well-positioned for growth due to its strong R&D capabilities, extensive pipeline, and effective leadership, presenting a buying opportunity after a recent sell-off.

    Read the full thesis
  • December 2024

    Ferguson is well-positioned for long-term growth due to its efficient operations, extensive distribution networks, and the advantages of scale in a consolidating industry.

    Read the full thesis
  • December 2024

    KLA is well-positioned for long-term growth due to high switching costs, strong demand for advanced semiconductors, and effective management, despite recent stock price concerns related to weaker demand in China.

    Read the full thesis

Letter archive · 14

Funds · 8

  • Parnassus Value Equity Fund3
  • Parnassus Core Equity Fund2
  • Parnassus Growth Equity Fund2
  • Parnassus Mid Cap Fund2
  • Parnassus Mid Cap Growth Fund2
  • Parnassus Core Select ETF1
  • Parnassus International Equity Fund1
  • Parnassus Value Select ETF1

Get Parnassus Investments’s next letter the day it lands

We track Parnassus Investments alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.

View plans
Share this fund